Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
HBS Fund Investors Society 2021 Report
  • Archive
  • Alumni Home
  • Giving
  • Diversity & Equity
  • Educational Innovation
  • Faculty & Research
  • Financial Aid
  • Global Understanding
  • University Collaborations
  • Member List
  • …→
  • Harvard Business School→
  • Investors Society Report→
  • Financial Aid→

Financial Aid

Financial Aid

From Scholarships to Life-Saving Impact

 
Nora Rabah (MS/MBA 2022), who emigrated to the United States as a child, remembers the hardship of growing up without health care and wants to make drugs for children with rare diseases more accessible and affordable.
Nora Rabah’s (MS/MBA 2022) interest in health care sprang from childhood. She was just five years old when her family emigrated to the United States from Syria. “Growing up, I remember we avoided doctors because we weren’t citizens and didn’t understand how to navigate this country’s complex health care system,” explains Rabah, who is now a proud citizen. “We were afraid of ending up with huge medical bills we couldn’t pay.”
Nora Rabah (MS/MBA 2022), who emigrated to the United States as a child, remembers the hardship of growing up without health care and wants to make drugs for children with rare diseases more accessible and affordable.

Inspired by this personal experience, Rabah chose to build a career in health care. She studied biology as an undergraduate at Cornell, where she developed a strong interest in drug pricing and pharmaceutical management. “I hope to be able to lower prices and expand access to life-saving therapies,” she says.

After college, Rabah joined the biotech company Sio Gene Therapies, where she had the opportunity to speak with parents of children with Tay-Sachs disease, an ultra-rare condition with no effective treatment. “It became abundantly clear to me that listening to patients and families is critical to driving innovation and ultimately, to breaking the boundaries of current therapy,” she says. “For example, their input can help determine which endpoints to measure or how to plan clinical trials.”

Rabah looks forward to becoming an executive in biotech—or perhaps founding her own company. To do so, she knew she needed to hone her managerial and leadership skills. Harvard’s new joint MS/MBA Biotechnology: Life Sciences degree felt like the perfect fit. “I ultimately chose the program because of its emphasis on ethical decision making,” she says. “I believe it will equip me with the tools necessary to make transformative medicines.”

“Growing up, I remember we avoided doctors because we weren’t citizens . . . [and] were afraid of ending up with huge medical bills we couldn’t pay.”
Nora Rabah
MS/MBA 2022
“Growing up, I remember we avoided doctors because we weren’t citizens . . . [and] were afraid of ending up with huge medical bills we couldn’t pay.”
Nora Rabah
MS/MBA 2022

Generous scholarship support was key to Rabah’s ability to enroll in the program. “I am grateful because I wouldn’t be here without donors,” says Rabah. “Thanks to scholarships, I will be able to choose a career that I find impactful and meaningful rather than seek a job just to pay off loans.” In turn, Rabah adds, “I hope donors take some credit for the positive impact HBS students like me have in the future.”

At HBS, Rabah is continuing her pursuit of expanding access to therapies for children with rare diseases. This past summer, she interned at Genentech in San Francisco, where she worked on the commercial marketing team for the neuro rare disease group. “I helped patients with spinal muscular atrophy get access to disease-modifying therapy,” she says.

After graduation, she plans to work at a mission-driven health care company that is focused on patients. “Patients and their families are at the center of why I want to be in the biotechnology space,” she concludes. “When you’re working on rare diseases, it’s hard not to feel like you’re making a difference.”

Nora Rabah (MS/MBA 2022), who emigrated to the United States as a child, remembers the hardship of growing up without health care and wants to make drugs for children with rare diseases more accessible and affordable.
Reflecting on the Importance of Scholarships
In a short video, David Chan (MBA 2018) talks about what scholarships have meant to him—as a student and today as an entrepreneur. Scholarships enabled him to attend HBS, pursue his interest in climate change on campus, and ultimately develop the skills and courage to help found FarmTogether, a startup that makes sustainable farmland investments available to all investors.

New Financial Aid Support

 Thumbnail
HBS introduced two new scholarships in 2020 in response to the evolving needs of students. A COVID Hardship Fund helped students whose financial circumstances were negatively affected by the pandemic, and a Childcare Scholarship was piloted to help families in which parents are in school or working. These scholarships joined an already comprehensive financial aid program that makes HBS accessible to talented students regardless of their backgrounds. Nearly 50 percent of MBA students receive need-based financial aid, and all doctoral students receive a fellowship that includes tuition and a generous living stipend.
→Financial aid website
ǁ
Campus Map
Donor Relations
Harvard Business School
Soldiers Field
Boston, MA 02163
Phone: 1.617.495.4957
Email: donorrelations@hbs.edu
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College